A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05787691` - Enhanced vs.Standard Pain Management of Patients at Risk for Chronic Post-surgical Pain	N/A
Recruiting	`NCT05764681` - Chronic Postsurgical Pain
Completed	`NCT04876989` - The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Paravertebral Block	N/A
Recruiting	`NCT05739747` - Validation of the Gendolcat Score for the Prognosis of Chronic Postoperative Pain in Cesarean Section

See also

Status

Clinical Trial

Phase

Recruiting

NCT05787691 - Enhanced vs.Standard Pain Management of Patients at Risk for Chronic Post-surgical Pain

N/A

Recruiting

NCT05764681 - Chronic Postsurgical Pain

Completed

NCT04876989 - The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Paravertebral Block

N/A

Recruiting

NCT05739747 - Validation of the Gendolcat Score for the Prognosis of Chronic Postoperative Pain in Cesarean Section

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02335229
Study type	Observational
Source	Abbott Medical Devices
Contact
Status	Terminated
Phase
Start date	June 2013
Completion date	February 2017

A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimulator System in Chronic Post Surgical Pain

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms